Chitosan caged liposomes for improving oral bioavailability of rivaroxaban: in vitro and in vivo evaluation

References

• Acosta E. 2009. Bioavailability of nanoparticles in nutrient and nutraceutical delivery. Curr Opin Colloid Interface Sci. 14(1):3–15.
   Web of Science ®Google Scholar
• Adelmann D, Wiegele M, Wohlgemuth RK, Koch S, Frantal S, Quehenberger P, Scharbert G, Kozek–Langenecker S, Schaden E. 2014. Measuring the activity of apixaban and rivaroxaban with rotational thrombelastometry. Thromb Res. 134(4):918–923.
   PubMed Web of Science ®Google Scholar
• Alavi S, Haeri A, Dadashzadeh S. 2017. Utilization of chitosan-caged liposomes to push the boundaries of therapeutic delivery. Carbohydr Polym. 157:991–1012.
   PubMed Web of Science ®Google Scholar
• Alomrani AH, Shazly GA, Amara AA, Badran MM. 2014. Itraconazole-hydroxypropyl-β-cyclodextrin loaded deformable liposomes: in vitro skin penetration studies and antifungal efficacy using Candida albicans as model. Colloids Surf B Biointerfaces. 121:74–81.
   PubMed Web of Science ®Google Scholar
• Alshamsan A, Aleanizy FS, Badran M, Alqahtani FY, Alfassam H, Almalik A, Alosaimy S. 2019. Exploring anti-MRSA activity of chitosan-coated liposomal dicloxacillin. J Microbiol Methods. 156:23–28.
   PubMed Web of Science ®Google Scholar
• Alshraim MO, Sangi S, Harisa GI, Alomrani AH, Yusuf O, Badran MM. 2019. Chitosan-coated flexible liposomes magnify the anticancer activity and bioavailability of docetaxel: impact on composition. Molecules. 24(2):250.
   PubMed Web of Science ®Google Scholar
• Badran M. 2014. Formulation and in vitro evaluation of flufenamic acid loaded deformable liposomes for improved skin delivery. DJNB. 9(1):83–91.
   Google Scholar
• Bangham A, De Gier J, Greville G. 1967. Osmotic properties and water permeability of phospholipid liquid crystals. Chem Phys Lipids. 1(3):225–246.
   Google Scholar
• Bangham AD, Horne R. 1964. Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J Mol Biol. 8(5):660–IN610.
   PubMed Web of Science ®Google Scholar
• Bian Y, Gao D, Liu Y, Li N, Zhang X, Zheng RY, Wang Q, Luo L, Dai K. 2015. Preparation and study on anti-tumor effect of chitosan-coated oleanolic acid liposomes. RSC Adv. 5(24):18725–18732.
   Web of Science ®Google Scholar
• Biemond BJ, Perzborn E, Friederich PW, Levi M, Buetehorn U, Büller HR. 2007. Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939)–an oral, direct factor Xa inhibitor. Thromb Haemost. 97(03):471–477.
   PubMed Web of Science ®Google Scholar
• Bruylants G, Wouters J, Michaux C. 2005. Differential scanning calorimetry in life science: thermodynamics, stability, molecular recognition and application in drug design. Curr Med Chem. 12(17):2011–2020.
   PubMed Web of Science ®Google Scholar
• Çelebier M, Reçber T, Koçak E, Altinöz S. 2013. RP-HPLC method development and validation for estimation of rivaroxaban in pharmaceutical dosage forms. Braz J Pharm Sci. 49(2):359–366.
   Web of Science ®Google Scholar
• Chalmers E, Ganesen V, Liesner R, Maroo S, Nokes T, Saunders D, Williams M, British Committee for Standards in Haematology 2011. Guideline on the investigation, management and prevention of venous thrombosis in children. Br J Haematol. 154(2):196–207.
   PubMed Web of Science ®Google Scholar
• Chen H, Pan H, Li P, Wang H, Wang X, Pan W, Yuan Y. 2016. The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system. Colloids Surf, B. 143:455–462.
   PubMed Web of Science ®Google Scholar
• Cho YW, Lee J, Lee SC, Huh KM, Park K. 2004. Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles. J Control Release. 97(2):249–257.
   PubMed Web of Science ®Google Scholar
• Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, Khorasani S, Mozafari M. 2018. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 10(2):57.
   PubMed Web of Science ®Google Scholar
• Ding T, Chen L, Zhai L-H, Fu Y, Sun B-W. 2017. Compatibility study of rivaroxaban and its pharmaceutical excipients. J Therm Anal Calorim. 130(3):1569–1573.
   Web of Science ®Google Scholar
• Dragicevic-Curic N, Gräfe S, Gitter B, Winter S, Fahr A. 2010. Surface charged temoporfin-loaded flexible vesicles: in vitro skin penetration studies and stability. Int J Pharm. 384(1-2):100–108.
   PubMed Web of Science ®Google Scholar
• El Zaafarany GM, Awad GA, Holayel SM, Mortada ND. 2010. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm. 397(1-2):164–172.
   PubMed Web of Science ®Google Scholar
• Friedrich I, Müller-Goymann C. 2003. Characterization of solidified reverse micellar solutions (SRMS) and production development of SRMS-based nanosuspensions. Eur J Pharm Biopharm. 56(1):111–119.
   PubMed Web of Science ®Google Scholar
• Gao Y, Li Z, Sun M, Li H, Guo C, Cui J, Li A, Cao F, Xi Y, Lou H, et al. 2010. Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer. Drug Dev Ind Pharm. 36(10):1225–1234.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Rodriguez M, Barros L, Palma J, Gonzalez-Rodriguez P, Rabasco A. 2007. Application of statistical experimental design to study the formulation variables influencing the coating process of lidocaine liposomes. Int J Pharm. 337(1-2):336–345.
   PubMed Web of Science ®Google Scholar
• Gregoriadis G, Florence AT. 1993. Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential" Drugs. 45(1):15–28.
   PubMed Web of Science ®Google Scholar
• Jøraholmen MW, Vanić Ž, Tho I, Škalko-Basnet N. 2014. Chitosan-coated liposomes for topical vaginal therapy: Assuring localized drug effect. Int J Pharm. 472(1-2):94–101.
   PubMed Web of Science ®Google Scholar
• Keller RJ. 1986. The sigma library of FT-IR spectra. 1st ed. Vol. 1–2. Sigma Chemical Company. 630–0101.
   Google Scholar
• Kubitza D, Becka M, Wensing G, Voith B, Zuehlsdorf M. 2005. Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939-an oral, direct Factor Xa inhibitor-after multiple dosing in healthy male subjects. Eur J Clin Pharmacol. 61(12):873–880.
   PubMed Web of Science ®Google Scholar
• Li N, Zhuang C, Wang M, Sun X, Nie S, Pan W. 2009. Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int J Pharm. 379(1):131–138.
   PubMed Web of Science ®Google Scholar
• Liu W, Liu J, Liu W, Li T, Liu C. 2013. Improved physical and in vitro digestion stability of a polyelectrolyte delivery system based on layer-by-layer self-assembly alginate-chitosan-coated nanoliposomes. J Agric Food Chem. 61(17):4133–4144.
   PubMed Web of Science ®Google Scholar
• Los DA, Murata N. 2004. Membrane fluidity and its roles in the perception of environmental signals. Biochim Biophys Acta. 1666(1-2):142–157.
   PubMed Web of Science ®Google Scholar
• Mady MM, Darwish MM, Khalil S, Khalil WM. 2009. Biophysical studies on chitosan-coated liposomes. Eur Biophys J. 38(8):1127–1133.
   PubMed Web of Science ®Google Scholar
• Mendelsohn R, Moore DJ. 1998. Vibrational spectroscopic studies of lipid domains in biomembranes and model systems. Chem Phys Lipids. 96(1-2):141–157.
   PubMed Web of Science ®Google Scholar
• Metre S, Mukesh S, Samal SK, Chand M, Sangamwar AT. 2018. Enhanced biopharmaceutical performance of rivaroxaban through polymeric amorphous solid dispersion. Mol Pharm. 15(2):652–668.
   PubMed Web of Science ®Google Scholar
• Mueck W, Stampfuss J, Kubitza D, Becka M. 2014. Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban. Clin Pharmacokinet. 53(1):1–16.
   PubMed Web of Science ®Google Scholar
• Musson DG, Kramer WG, Foehr ED, Bieberdorf FA, Hornfeldt CS, Kim SS, Dorenbaum A. 2010. Relative bioavailability of sapropterin from intact and dissolved sapropterin dihydrochloride tablets and the effects of food: a randomized, open-label, crossover study in healthy adults. Clin Ther. 32(2):338–346.
   PubMed Web of Science ®Google Scholar
• Newall F, Wallace T, Crock C, Campbell J, Savoia H, Barnes C, Monagle P. 2006. Venous thromboembolic disease: A single-centre case series study. J Paediatr Child Health. 42(12):803–807.
   PubMed Web of Science ®Google Scholar
• Nguyen TX, Huang L, Liu L, Abdalla AME, Gauthier M, Yang G. 2014. Chitosan-coated nano-liposomes for the oral delivery of berberine hydrochloride. J Mater Chem B. 2(41):7149–7159.
   PubMed Web of Science ®Google Scholar
• Panwar P, Pandey B, Lakhera P, Singh K. 2010. Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes. Int J Nanomedicine. 5:101.
   PubMed Web of Science ®Google Scholar
• Patro SK, Jhansi M, Babu AS, Asief S, Babu PR. Drug-excipient compatability studies using thermal methods. [accessed 2020 Feb 13]. https://pharmachitchat.wordpress.com/2015/05/28/drug-excipient-compatability-studies-using-thermal-methods/
   Google Scholar
• Perez AP, Altube MJ, Schilrreff P, Apezteguia G, Celes FS, Zacchino S, de Oliveira CI, Romero EL, Morilla MJ. 2016. Topical amphotericin B in ultradeformable liposomes: Formulation, skin penetration study, antifungal and antileishmanial activity in vitro. Colloids Surf B Biointerfaces. 139:190–198.
   PubMed Web of Science ®Google Scholar
• Putri DCA, Dwiastuti R, Marchaban M, Nugroho AK. 2017. Optimization of mixing temperature and sonication duration in liposome preparation. JPharmSciCommunity. 14(2):79–85.
   Google Scholar
• Qandil AM, Obaidat AA, Ali MAM, Al-Taani BM, Tashtoush BM, Al-Jbour ND, Al Remawi MM, Al-Sou’od KA, Badwan AA. 2009. Investigation of the interactions in complexes of low molecular weight chitosan with ibuprofen. J Solution Chem. 38(6):695–712.
   Web of Science ®Google Scholar
• Raffini L, Huang Y-S, Witmer C, Feudtner C. 2009. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics. 124(4):1001–1008.
   PubMed Web of Science ®Google Scholar
• Ribas A, Zhang W, Chang I, Shirai K, Ernstoff MS, Daud A, Cowey CL, Daniels G, Seja E, O'Laco E, et al. 2014. The effects of a high-fat meal on single-dose vemurafenib pharmacokinetics. J Clin Pharmacol. 54(4):368–374.
   PubMed Web of Science ®Google Scholar
• Sayyad M, Zaky A, Samy A. 2017. Fabrication and Characterization of Sildenafil Citrate Loaded Transfersomes as a Carrier for Transdermal Drug Delivery. Pharm Pharmacol Int J. 5(2):00113.
   Google Scholar
• Sekaran CB, Bind VH, Damayanthi MR, Sireesha A. 2013. Development and validation of UV spectrophotometric method for the determination of rivaroxaban. Der Pharma Chemica. 5(1):1–5.
   Google Scholar
• Severcan F, Sahin I, Kazancı N. 2005. Melatonin strongly interacts with zwitterionic model membranes-evidence from Fourier transform infrared spectroscopy and differential scanning calorimetry. Biochim Biophys Acta. 1668(2):215–222.
   PubMed Web of Science ®Google Scholar
• Shin GH, Chung SK, Kim JT, Joung HJ, Park HJ. 2013. Preparation of chitosan-coated nanoliposomes for improving the mucoadhesive property of curcumin using the ethanol injection method. J Agric Food Chem. 61(46):11119–11126.
   PubMed Web of Science ®Google Scholar
• Stampfuss J, Kubitza D, Becka M, Mueck W. 2013. The effect of food on the absorption and pharmacokinetics of rivaroxaban. Int J Clin Pharmacol Ther. 51(7):549–561.
   PubMed Web of Science ®Google Scholar
• Tian M, Han J, Ye A, Liu W, Xu X, Yao Y, Li K, Kong Y, Wei F, Zhou W. 2019. Structural characterization and biological fate of lactoferrin-loaded liposomes during simulated infant digestion. J Sci Food Agric. 99(6):2677–2684.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. 2005. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 4(2):145–160.
   PubMed Web of Science ®Google Scholar
• Wan S, Sun Y, Qi X, Tan F. 2012. Improved bioavailability of poorly water-soluble drug curcumin in cellulose acetate solid dispersion. Aaps Pharmscitech. 13(1):159–166.
   PubMed Web of Science ®Google Scholar
• Wang D, Chen G, Ren L. 2017. Preparation and characterization of the sulfobutylether-β-cyclodextrin inclusion complex of amiodarone hydrochloride with enhanced oral bioavailability in fasted state. AAPS PharmSciTech. 18(5):1526–1535.
   PubMed Web of Science ®Google Scholar
• Wang M, Zhao T, Liu Y, Wang Q, Xing S, Li L, Wang L, Liu L, Gao D. 2017. Ursolic acid liposomes with chitosan modification: Promising antitumor drug delivery and efficacy. Mater Sci Eng C Mater Biol Appl. 71:1231–1240.
   PubMed Web of Science ®Google Scholar
• Wang Q, Lv S, Lu J, Jiang S, Lin L. 2015. Characterization, stability, and in vitro release evaluation of carboxymethyl chitosan coated liposomes containing fish oil. J Food Sci. 80(7):C1460–C1467.
   PubMed Web of Science ®Google Scholar
• Williams RO III, Mahaguna V, Sriwongjanya M. 1998. Characterization of an inclusion complex of cholesterol and hydroxypropyl-β-cyclodextrin. Eur J Pharm Biopharm. 46(3):355–360.
   PubMed Web of Science ®Google Scholar
• Xue X, Cao M, Ren L, Qian Y, Chen G. 2018. Preparation and optimization of rivaroxaban by self-nanoemulsifying drug delivery system (SNEDDS) for enhanced oral bioavailability and no food effect. AAPS PharmSciTech. 19(4):1847–1859.
   PubMed Web of Science ®Google Scholar
• Yu LX, Straughn AB, Faustino PJ, Yang Y, Parekh A, Ciavarella AB, Asafu-Adjaye E, Mehta MU, Conner DP, Lesko LJ, et al. 2004. The effect of food on the relative bioavailability of rapidly dissolving immediate-release solid oral products containing highly soluble drugs. Mol Pharm. 1(5):357–362.
   PubMed Web of Science ®Google Scholar
• Zhao GD, Sun R, Ni SL, Xia Q. 2015. Development and characterisation of a novel chitosan-coated antioxidant liposome containing both coenzyme Q10 and alpha-lipoic acid. J Microencapsul. 32(2):157–165.
   PubMed Web of Science ®Google Scholar